Revvity Inc vs iShares Silver Trust — how do they compare? Revvity Inc trades at $117.6 (market cap $12.91B), while iShares Silver Trust trades at $58.98. The key difference: Revvity Inc pays a 0.24% dividend while iShares Silver Trust pays none, and Revvity Inc is trading nearer its 52-week high, iShares Silver Trust nearer its low. Which is the better fit depends on your goals.
| RVTY | SLV | |
|---|---|---|
Market Cap | $12.91B | — |
Sector | Technology | — |
52-Week High | $117.75 | $105.57 |
52-Week Low | $82.26 | $33.89 |
Enterprise Value | $15.23B | — |
Dividend Yield | 0.24% | — |
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $117.88, up 1.6% today, with a bullish technical outlook and strong earnings momentum after beating Q2 2026 EPS estimates. The stock is near the consensus price target of $120.50, supported by a 51.72% analyst buy rating. Recent news highlights product launches like the SuperFlex prenatal system and investor conference participation, reinforcing growth prospects in diagnostics and biotech tools.
The outlook remains positive with revenue stability and margin strength, but elevated P/E of 55.64 poses valuation risk. Key opportunities include diagnostic demand and AI-driven workflows, while risks involve competitive pressures and execution challenges. Net cash flow turned positive in 2026, signaling improved financial health.
SLV, tracking physical silver, trades at $59.06, down 0.59% on the day, with a bullish technical signal from moving averages but neutral oscillators. Recent news highlights silver's rebound driven by data center demand and Fed policy expectations, though prices eased ahead of CPI data. Financial ratios are not applicable as SLV is a commodity trust.
The outlook for SLV hinges on industrial demand and macroeconomic trends, with upside potential from Fed dovishness but risks from dollar strength and inflation data. Investors gain silver exposure without company fundamentals, making price movements key.
Trailing returns across standard periods
Latest headlines on both assets
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →The ETF seeks to reflect such performance before payment of the ETF's expenses and liabilities. It is not actively managed. The ETF does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of silver.
Read more on SLV →